Risultati della ricerca - Cassianne Robinson‐Cohen
- Mostra 1 - 20 risultati su 60
- Vai alla pagina seguente
-
1
-
2
Aldosterone, Parathyroid Hormone, and the Use of Renin-Angiotensin-Aldosterone System Inhibitors: The Multi-Ethnic Study of Atherosclerosis di Jenifer M. Brown, Ian H. de Boer, Cassianne Robinson‐Cohen, David S. Siscovick, Bryan Kestenbaum, Matthew Allison, Anand Vaidya
Pubblicazione 2014Artigo -
3
-
4
Association of markers of endothelial dysregulation Ang1 and Ang2 with acute kidney injury in critically ill patients di Cassianne Robinson‐Cohen, Ronit Katz, Brenda Price, Susanna Harju-Baker, Carmen Mikacenic, Jonathan Himmelfarb, W. Conrad Liles, Mark M. Wurfel
Pubblicazione 2016Artigo -
5
-
6
-
7
-
8
-
9
Racial Differences in the Association of Serum 25-Hydroxyvitamin D Concentration With Coronary Heart Disease Events di Cassianne Robinson‐Cohen, Andrew N. Hoofnagle, Joachim H. Ix, Michael C. Sachs, Russell P. Tracy, David S. Siscovick, Bryan Kestenbaum, Ian H. de Boer
Pubblicazione 2013Artigo -
10
-
11
-
12
Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial di Matthew B. Rivara, Catherine K. Yeung, Cassianne Robinson‐Cohen, Brian Phillips, John Ruzinski, Denise A. Rock, Lori Linke, Danny D. Shen, T. Alp İkizler, Jonathan Himmelfarb
Pubblicazione 2016Artigo -
13
-
14
-
15
The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease di Cortney Bosworth, Gregory P. Levin, Cassianne Robinson‐Cohen, Andrew N. Hoofnagle, John Ruzinski, Bessie A. Young, Stephen M. Schwartz, Jonathan Himmelfarb, Bryan Kestenbaum, Ian H. de Boer
Pubblicazione 2012Artigo -
16
Mineral Metabolism Markers and the Long-Term Risk of Hip Fracture: The Cardiovascular Health Study di Cassianne Robinson‐Cohen, Ronit Katz, Andrew N. Hoofnagle, Jane A. Cauley, Curt D. Furberg, John A. Robbins, Chen Zhao, David S. Siscovick, Ian H. de Boer, Bryan Kestenbaum
Pubblicazione 2011Artigo -
17
Association between Physical Performance and All-Cause Mortality in CKD di Baback Roshanravan, Cassianne Robinson‐Cohen, Kushang V. Patel, Ernest Ayers, Alyson J. Littman, Ian H. de Boer, T. Alp İkizler, Jonathan Himmelfarb, Leslie I. Katzel, Bryan Kestenbaum, Stephen L. Seliger
Pubblicazione 2013Artigo -
18
Serum Parathyroid Hormone and 25‐Hydroxyvitamin D Concentrations and Risk of Incident Heart Failure: The Multi‐Ethnic Study of Atherosclerosis di Nisha Bansal, Leila R. Zelnick, Cassianne Robinson‐Cohen, Andy Hoofnagle, Joachim H. Ix, João A.C. Lima, Abigail B. Shoben, Carmen Peralta, David S. Siscovick, Bryan Kestenbaum, Ian H. de Boer
Pubblicazione 2014Artigo -
19
Health Outcome Priorities of Older Adults with Advanced CKD and Concordance with Their Nephrology Providers’ Perceptions di Sarah Ramer, Natalie McCall, Cassianne Robinson‐Cohen, Edward D. Siew, Huzaifah Salat, Aihua Bian, Thomas G. Stewart, Maie El-Sourady, Mohana Karlekar, Loren Lipworth, T. Alp İkizler, Khaled Abdel-Kader
Pubblicazione 2018Artigo -
20
Risk factors for hip and vertebral fractures in chronic kidney disease: the CRIC study di Simon Hsu, Nisha Bansal, Michelle Denburg, Charles Ginsberg, Andrew N. Hoofnagle, Tamara Isakova, Joachim H. Ix, Cassianne Robinson‐Cohen, Myles Wolf, Bryan Kestenbaum, Ian H. de Boer, Leila R. Zelnick
Pubblicazione 2024Artigo
Strumenti per la ricerca:
Soggetti correlati
Medicine
Internal medicine
Endocrinology
Kidney disease
Renal function
Biology
Gene
Genetics
Confidence interval
Creatinine
Environmental health
Population
Vitamin D and neurology
Cohort
Genotype
Cardiology
Acute kidney injury
Hazard ratio
Intensive care medicine
Diabetes mellitus
Prospective cohort study
Single-nucleotide polymorphism
Biochemistry
Blood pressure
Chemistry
Cohort study
Genome-wide association study
Heart failure
Physical therapy
Proportional hazards model